Altres projectes internacionals

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

II Synergy Workshop on Translational and Clinical Oncology applied to Environmental & Occupational Cancer: Focus on Radon.

Efecto del Tratamiento agudo con corticoides endovenosos en las partes blandas en fracturas de pilón tibial, retropié y mediopié en relación con tiempo desde ingreso hasta tratamiento quirúrgico

MOLECULAR MEASURABLE RESIDUAL DISEASE (MRD) MONITORING BY HIGH-THROUGHPUT TECHNIQUES IN PATIENTS TREATED WITH CART19 THERAPY

Early detection of perianal fistulizing - Early detection of perianal fistulizing disease- Pathophysiology and Imaging

HUNTER: Hepatocellular Carcinoma Expediter Network

CRCNS US-Spanish Research Proposal: Circuit mechanisms of priors and learning during decision making

Psoriasis, a metabolic dysregulation of the innate immune system? Targeting ZEB1 in macrophages as a new therapeutic approach to psoriasis

PPMI - Parkinson's Progression Markers Initiative (PPMI) study

Deciphering the molecular signatures of gestational food cravings as drivers of eating disorders in the offspring

Effects of circulating extracellular vesicles on pancreatic islets during obesity

A new target for the treatment of acute and chronic itch

Type 2 inflammation and olfactory loss in chronic rhinosinusitis with nasal polyps: Role of Mepolizumab in olfactory cell neurogenesis

Preclinical evaluation of Lilly LRRK2 inhibitors for Parkinson's disease using phosphoproteomic analysis

Dissecting the role of the 14q32 region in hepatoblastoma "Hblast14"

Dissecting the cellular and molecular atlas of Rheumatoid Arthritis (RA) in sustained remission to identify pathways maintaining Remission and Triggering Flares

Cell-Specific Epigenomic Changes in iPSC-Derived Oligodendrocytes from MSA Patients: Effects of α-Synuclein Fibril Exposure in a Disease-Specific Cell Model

Decoding tanycytic mitochondrial dynamics in nutrient sensing and metabolic health.

COVID-19 in patients under treatment with anti-CD20 monoclonals: clinical features and outcome

Mutimodal single cell profiling of tumor cell and microenvironment interactions driving clinical evolution and therapeutic responses in Mantle Cell Lymphoma

EHIN - Epithelioid Hemangioendothelioma International Network.

RIBOLARIS-PREDICT - Genomic-Based Biomarkers for Predicting Ribociclib Response in Early-Stage Hormone Receptor-Positive and HER2-Negative Breast Cancer (RIBOLARIS-PREDICT)

ATLAX - Characterizing the signals from adipo-liver axis in NASH and unveiling their utility as disease biomarkers.

Single cell subclonal characterization and evolution of the genome and transcriptome in IgM monoclonal gammopathy

Transcriptomic impact of blocking IL-5 with mepolizumab on CD4+T lymphocytes from patients with EGPA. Search for predictors of response

Enabling Artificial Intelligence (AI) for Early Detection of Melanoma in Smartphone Images

PREDICTION OF TREATMENT NEEDS USING A HYBRID ARTIFICIAL INTELLIGENCE-BASED MANAGEMENT ASSISTANT (ALMA) TOOL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

MULTIlayer Predictive models for relapsed MCL after ibrutinib as first line therapY (MULTIPLY)

BioRTC Computational Neuroscience Course

RICHARDIII - A pilot study on the use of ARI-0003 cells (dual anti-CD19/CD9 chimeric antigen receptor T-cells) for patients with relapsed/refractory Richter's transformation

HeBA - Barcelona 2022 PPMI Healthy Brain Aging Initiative

CARTALLEU - Phase 2 clinical trial to evaluate the efficacy and safety of varnimcabtagene autoleucel for relapsed/refractory adult acute lymphoblastic leukaemia

PF_MARFANS_Egea - Financiación para un proyecto de investigación liderado por el Dr. Egea

MULTICENTER TRIAL OF VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (CART19-BE-02 TRIAL)

BLOOD a-SYNUCLEIN AGGREGATION ASSAY AS A NOVEL DIAGNOSTIC TOOL FOR PARKINSON’S DISEASE

The Edmond J. Safra Fellowship in Movement Disorders - Hospital Clinic Barcelona

RETRACER - RET Expression TRacking to Assess CDK4/6-Inhibitor and Endocrine therapy Resistance emergence

KALYX - (KRAS And Lung cancer: eXposome study) - The exposome study in KRAS-mutant non-small cell cancer patients

The ORCHID study - Overcoming Early Relapse on Adjuvant CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer: Mechanisms of Resistance and Therapeutic Strategies (The ORCHID Study).